Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Omegabrite

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed6

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 6 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Omegabrite1
  • Eicosapentaenoic Acid Ethyl Ester1

Active Sponsors

  • National Institute of Mental Health (NIMH)6

Top Investigators

Related Conditions

  • Healthy2
  • Bipolar Disorder2
  • Mood Disorder2
  • Osteoporosis1
  • Cardiovascular Disease1

Activity Timeline